pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Diagnostics Company · news · pharmadog
← back to Diagnostics Company
News · Diagnostics Company
132
stories
Oct 14, 26
Opinion: We think a baby’s gut microbiome could be key to lifelong brain health
stat
Oct 14, 26
Agilent spends $240M upfront to buy digital pathology specialist Proscia
fiercebiotech
Oct 13, 26
Insulet’s Omnipod Discover platform sees full market release in US
fiercebiotech
Oct 12, 26
Successful CDMO partnerships hinge on honest—and sometimes critical—support
biospace
Oct 11, 26
The 2026 Biotech Graveyard
fiercebiotech
Oct 8, 26
The Nobel boys club (again)
stat
Oct 8, 26
Breast cancer can behave differently in older women. This physician is making more tailored treatments a reality
stat
Oct 6, 26
GE HealthCare to acquire Sofie Biosciences for $945M
biopharma dive
Oct 5, 26
2 Massachusetts biotechs call it quits
biospace
Oct 5, 26
Precision for All: Closing the gap between innovation and impact
biopharma dive
Oct 2, 26
Immunotherapy startup Adecto blames ‘risk-averse funding environment’ for closing down
fiercebiotech
Oct 2, 26
Abbott launches SimpleScreen CRC blood test in the US
fiercebiotech
Oct 1, 26
Roche launches simultaneous screening test for SMA, SCID and SCD
fiercebiotech
Sep 28, 26
Regenerative medicine needs more than stem cells
biospace
Sep 24, 26
Grail multicancer detection test wins FDA advisers’ backing
biopharma dive
Sep 24, 26
Grail survives adcomm vote as it awaits FDA decision for cancer blood test
fiercebiotech
Sep 23, 26
FDA adcomm votes in favor of benefit-risk of Grail’s cancer test
endpoints
Sep 23, 26
Pharmas face off for manufacturing talent amidst reshoring efforts
biospace
Sep 22, 26
Siemens Healthineers and Novo team up on fatty liver disease awareness, testing
fiercebiotech
Sep 21, 26
FDA offers little comment on Grail cancer test ahead of adcomm
endpoints
Sep 21, 26
Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts
biospace
Sep 21, 26
Sleuth forecasts 2027 jump in Western license deals for Chinese radioligand therapies
biospace
Sep 21, 26
Telix buys ITM in bid to create a ‘radiopharmaceutical powerhouse’
biopharma dive
Sep 18, 26
FDA clears Aptitude’s latest Metrix molecular dx to test for COVID
fiercebiotech
Sep 16, 26
Convergence: Achieving representative enrollment in clinical trials
raps
Sep 16, 26
Convergence: Experts review the state of play for MDR/IVDR amid proposed reforms
raps
Sep 15, 26
Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure
fiercebiotech
Sep 15, 26
After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer
fiercebiotech
Sep 14, 26
Unlocking cell surface protein research with site-specific labeling
biospace
Sep 13, 26
J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg
fiercebiotech
← prev
page 2 of 5
next →